BMRN
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Distressed
# of Employee: 2,158 / Fiscal Year End: 2016-12-31 / Stock Type: Mid Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | GILD | CELG | NVO | BIIB | SHPG | REGN | ALXN | VRTX | INCY | VVUS |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2016-12-25Quarter300,091k64,147k8,841k-78,711k-78,711k172,228,k78.60%-26.20%-26.20%
2017-03-25Quarter303,745k50,006k9,233k-16,290k-16,290k172,710,k83.50%-5.40%-5.40%
2017-06-25Quarter317,448k56,305k9,154k-36,833k-36,833k174,374,k82.30%-11.60%-11.60%
2017-09-25Quarter334,148k59,480k9,746k-12,527k-12,527k175,103,k82.20%-3.70%-3.70%
2017-12-25Quarter358,305k75,995k10,849k-51,392k-51,392k175,495,k78.80%-14.30%-14.30%
2018-03-25Quarter373,447k82,333k10,558k-44,149k-44,149k176,150,k78.00%-11.80%-11.80%
2018-06-25Quarter372,845k79,019k11,219k-16,792k-16,792k176,873,k78.80%-4.50%-4.50%
2018-09-25Quarter391,706k78,893k11,123k-12,620k-12,620k177,481,k79.90%-3.20%-3.20%
2018-12-25Quarter353,214k75,019k7,154k-3,650k-3,650k178,771,k78.80%-1.00%-1.00%
2019-03-25Quarter400,745k89,182k6,727k-56,473k-56,473k178,271,k77.70%-14.10%-14.10%
2019-06-25Quarter387,763k77,436k6,400k-37,435k-37,435k179,048,k80.00%-9.70%-9.70%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2017-12-25Quarter19.40%18.47%22.71%-34.71%-34.71%1.90%0.25%-45.42%-45.42%
2018-03-25Quarter22.95%64.65%14.35%171.02%171.02%1.99%-6.59%118.52%118.52%
2018-06-25Quarter17.45%40.34%22.56%-54.41%-54.41%1.43%-4.25%-61.21%-61.21%
2018-09-25Quarter17.23%32.64%14.13%0.74%0.74%1.36%-2.80%-13.51%-13.51%
2018-12-25Quarter-1.42%-1.28%-34.06%-92.90%-92.90%1.87%0.00%-93.01%-93.01%
2019-03-25Quarter7.31%8.32%-36.29%27.91%27.91%1.20%-0.38%19.49%19.49%
2019-06-25Quarter4.00%-2.00%-42.95%122.93%122.93%1.23%1.52%115.56%115.56%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter2,766,275k4,023,690k1,257,415k1,421,791k439,310k818,105k2.200.309
2017-03-25Quarter2,769,087k3,938,607k1,169,520k1,352,788k340,206k829,314k2.368.251
2017-06-25Quarter2,795,579k4,019,965k1,224,386k1,458,820k374,303k850,083k2.283.257
2017-09-25Quarter2,813,562k4,580,697k1,767,135k2,050,029k417,529k1,349,606k1.592.204
2017-12-25Quarter2,808,663k4,633,125k1,824,462k2,207,144k816,518k1,007,944k1.539.370
2018-03-25Quarter2,807,003k4,596,717k1,789,714k2,241,110k773,471k1,016,243k1.568.345
2018-06-25Quarter2,885,104k4,624,679k1,739,575k2,280,067k804,950k934,625k1.659.353
2018-09-25Quarter2,914,945k4,695,254k1,780,309k2,407,853k838,660k941,649k1.637.348
2018-12-25Quarter2,967,940k4,427,128k1,459,188k2,056,215k523,241k935,947k2.034.254
2019-03-25Quarter2,936,627k4,435,398k1,498,771k1,916,855k500,986k997,785k1.959.261
2019-06-25Quarter9,196k0.00.01,432,430k10,165k223,947k∞.007

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter1.53%15.15%45.10%55.24%85.86%23.20%-30.05%19.74%
2018-03-25Quarter1.37%16.71%53.03%65.67%127.35%22.54%-33.78%37.45%
2018-06-25Quarter3.20%15.04%42.08%56.30%115.05%9.95%-27.33%37.35%
2018-09-25Quarter3.60%2.50%0.75%17.45%100.86%-30.23%2.83%70.59%
2018-12-25Quarter5.67%-4.45%-20.02%-6.84%-35.92%-7.14%32.16%-31.35%
2019-03-25Quarter4.62%-3.51%-16.26%-14.47%-35.23%-1.82%24.94%-24.35%
2019-06-25Quarter-99.68%-100.00%-100.00%-37.18%-98.74%-76.04%-100.00%-98.02%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note